HIMS
Hims & Hers Health, Inc.
stock NYSE

Anything behind this administration focused on reducing cost? Like why not allow compounding?
Also wasn't HIMS about to distribute for Novo?
I think I'm still bullish, they are building the infrastructure to deliver, if this admin relaxes on the GLP 1, would be huge

Anything behind this administration focused on reducing cost? Like why not allow compounding?
Also wasn't HIMS about to distribute for Novo?
I think I'm still bullish, they are building the infrastructure to deliver, if this admin relaxes on the GLP 1, would be huge

If only you’d done that instead of losing $75k on HIMS.

huh... [https://finance.yahoo.com/quote/HIMS/](https://finance.yahoo.com/quote/HIMS/)
"As of 10/2/2025" wtf yahoo update your shit

Don’t listen to these people. You are correct. PayPal and the other one did not dip enough. Hims is literally pennies. I think it’s very similar to buying Wayfair a year ago. Everyone hated on them because who thinks online furniture should be worth billions, but it is.
I am writing on the March 20 calls for HIMS. And I was also planning on buying more on Monday.
It will squeeze. There isn’t any downside left

No $HIMS!?

Their business is Hims|Hers but the ticker is just HIMS thats misogynist, so I’m buying calls.

I lost a little more than that on PYPL, HOOD and SNAP earnings. Now I can’t decide if I should take my chances with HIMS tomorrow or if I should hold SNAP shares until they recover 50 %.

I lost 75k with $HIMS ... first loss in 6 Years of investing. I learned from it. Maybe you will too... someday.

Implied moves, 725 companies reporting. This is up or down idiot

$NVDA 6.7%
$CRWV 18.0%
$HD 4.5%
$LOW 4.7%
$TTD 15.3%
$CRM 9.9%
$SNOW 12.7%
$HIMS 15.5%
$RKLB 12.9%
$DELL 10.5%
$DPZ 8.2%
$CIFR 15.6%
$CRCL 10.6%
$AMC 21.7%
$INTU 9.8%
$MP 9.1%
$SMR 15.6%
$XYZ 11.2%
$ADSK 8.4%
$CLOV 14.4%
$CPNG 8.7%
$FIGS 20.5%
$FLUT 14.8%
$UUU 12.2%
$AXON 17.9%
$PLNT 10.9%
$SOUN 15.2%
$ZS 12.0%
$DUOL 15.8%
$IONQ 13.7%
$QBTS 14.5%
$CELH 13.9%

• Monday: $DPZ $HIMS $KTOS
• Tuesday: $HD $AMC $CAVA $AXON $CIFR $ZETA $WDAY $TEM $MELI
• Wednesday: $NVDA $CRM $TTD $SNOW $TJX $CRCL $HUT $IONQ
• Thursday: $CRWV $DELL $VST $QBTS $EOSE $MARA $RKLB $DUOL $BIDU
• Friday: $UUUU

Robinhood killed many of us. I think the sentiment on it is jaded. Coinbase and eToro were fine after their earnings. Yes, Hood is very much tied to crypto, but they crushed with gambling and have a ton in the pipeline (gambling, 24/7 trading, banking, social, Goldold, more customization like thinkorswim and tradingview, etc). The fact that it dropped 30% in the span of a little more than a month blows. Not as bad as HIMS, but for a decent company with good stuff on the horizon, it blows.

Hims & Hers Health (HIMS) is scheduled to report its Q4 2025 earnings on Monday, February 23, 2026, after the market closes.
Whether the stock will rally is currently a "tug-of-war" between impressive revenue growth and significant regulatory/legal hurdles. Here is the breakdown of the sentiment heading into the report:
Analysts are bracing for a "mixed bag" report where the top-line growth looks great, but the bottom line is under pressure.
HIMS has a history of beating revenue estimates (6 of the last 8 quarters). If they show that their non-GLP-1 business (hair loss, mental health) is thriving despite the noise, or if they provide strong 2026 guidance, the stock could bounce off its recent lows.
Earnings are expected to drop sharply due to aggressive marketing spend and legal costs. Recent sentiment has been "fragile," with the stock hitting 17-month lows just this month.
The stock has been extremely volatile lately (down \~50% in the last 30 days) due to two major factors:
The GLP-1 "Crackdown": The FDA and big pharma (Novo Nordisk) have increased scrutiny on compounded weight-loss drugs. Since this was a massive growth driver for HIMS, any negative commentary on the legality or future of their "compounded semaglutide" could sink the stock regardless of the numbers.
HIMS recently announced a $1.15 billion acquisition of Eucalyptus (an Australian telehealth firm). Investors will be looking for clarity on how this affects their cash flow and if it can offset potential losses in the US weight-loss market.
Implied Move: Options traders are pricing in a massive 17% swing (up or down) following the results. This is much higher than their historical average of 5–11%.
What do y’all think?

Wonder if HIMS would be a good play.

HIMS calls noway they gk over investors where stock will be at $10

HIMS is going nuts

People loading up on HIMS before the earnings or what?

long HIMS?

HIMS calls, hoping for dead cat bounce?

HIMS puts
RTX calls
It is known